Home > > > Report Detail

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights, Trends and Forecast (2019-2028)

Publisher Name :
Date: 26-Aug-2019
No. of pages: 96
Inquire Before Buying

The global Non-Alcoholic Steatohepatitis (NASH) drugs market is expected to reach US$61.60 billion in 2028, growing at a CAGR of 39.36%, for the duration spanning 2018-2028. The factors such as rising prevalence of NASH, increasing diabetic population, rising obesity, unmet medical needs and sedentary lifestyle are expected to drive the growth of the market. However, the market growth would be challenged by lethargic drug approval process, high treatment cost and less definitive diagnostic methods for NASH/NAFLD. A few notable trends include escalating market penetration for NASH major drugs, progressing NASH diagnosis methods and biomarkers, NASH pipeline drugs under development and growth in E-Commerce pharmaceutical products sales.

The global Non-Alcoholic Steatohepatitis (NASH) drugs market has two major segments, based on drug classes - Off-Label drugs and Therapeutic Drugs. The current NASH drugs market is wholly occupied by off-label drugs as there are no clinically approved medicines for the treatment of NASH. However, certain therapeutic drugs, from large pharmaceutical drugs, are expected to enter the market in coming years, with considerable market share. The need for definitive NASH treatment would lead to strong market penetration of the therapeutic drugs during the forecasted period.

The fastest growing regional market would be the U.S., due to the increasing prevalence of NASH, along with forthcoming launches of various NASH therapeutic drugs. Moreover, Europe is also expected to hold a significant share in the global NASH therapeutics market, owing to the growing awareness amongst the inhabitants, regarding NASH diagnosis and treatment methods.

Scope of the report:


  • The report provides a comprehensive analysis of the global Non-Alcoholic Steatohepatitis (NASH) Drugs market, segmented into Off Label Drugs and Therapeutic Drugs sub markets.

  • The major regional markets (the U.S. and Europe) have been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Bristol Myers Squibb, Gilead Sciences, Allergan Plc. (Tobira), Intercept Pharmaceuticals, Galmed Pharmaceuticals and Genfit SA) are also presented in detail.


Key Target Audience:


  • NAFLD/NASH Drugs Manufacturers

  • Chemical Suppliers

  • End Users (Hospital, Medical centers, Clinical Institutes)

  • Healthcare Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights, Trends and Forecast (2019-2028)

Table of Contents

1. Market Overview
1.1 Introduction
1.2 Causes & Symptoms
1.3 Diagnosis
1.4 Treatment
1.5 Off-Label Treatment
1.6 Therapeutic Treatment

2. Global NASH Market
2.1 Global NASH Drugs Market Forecast by Value
2.2 Global NASH Drugs Market Value Forecast by Drug Class
2.3 Global NASH Off-Label Drugs Market Forecast by Value

3. Global NASH Therapeutics Market
3.1 Global NASH Therapeutics Market Forecast by Value
3.2 Global NASH Therapeutics Market Value Forecast by Drug Type
3.2.1 Global NASH Therapeutics Market Value Forecast by Drug Type (2023)
3.2.2 Global NASH Therapeutics Market Value Forecast by Drug Type (2028)
3.2.3 Global Obeticholic Acid (OCA) Drug Market Forecast by Value
3.2.4 Global Obeticholic Acid (OCA) Drug Market Value Forecast by Region
3.2.5 Global Cenicriviroc (CVC) Drug Market Forecast by Value
3.2.6 Global Cenicriviroc (CVC) Drug Market Value Forecast by Region
3.2.7 Global Elafibranor Drug Market Forecast by Value
3.2.8 Global Aramchol Drug Market Forecast by Value
3.2.9 Global MGL-3196 Drug Market Forecast by Value
3.2.10 Global INN-217 Drug Market Forecast by Value
3.2.11 Global VK2809 Drug Market Forecast by Value
3.3 Global NASH Therapeutics Market Value Forecast by Region
3.3.1 Global NASH Therapeutics Market Value Forecast by Region (2023)
3.3.2 Global NASH Therapeutics Market Value Forecast by Region (2028)

4. Regional NASH Market
4.1 The U.S. NASH Therapeutics Market Forecast by Value
4.2 Europe NASH Therapeutics Market Forecast by Value
4.3 ROW NASH Therapeutics Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Prevalence of NASH
5.1.2 Rising HealthCare Expenditure
5.1.3 Increasing Diabetic Population
5.1.4 Rising Obesity
5.1.5 Unmet Medical Needs
5.1.6 Sedentary Lifestyle
5.2 Key Trends & Development
5.2.1 Escalating Market Penetration for NASH Major Drugs
5.2.2 Increase in Pharmaceutical R&D Expenditures
5.2.3 Progressing NASH Diagnosis Methods and Biomarkers
5.2.4 NASH Pipeline Drugs under Development
5.2.5 Growth in E-Commerce Pharmaceutical Products Sales
5.3 Challenges
5.3.1 Lethargic Drug Approval Process
5.3.2 High Treatment Cost
5.3.3 Associated Business Risk
5.3.4 Less Definitive Diagnostic Methods for NASH/NAFLD

6. Competitive Landscape
6.1 Global NASH Drugs Market
6.1.1 Key Players – Product Portfolio Comparison
6.1.2 Key Players – Phase II clinical trials in NASH with histological endpoints Comparison
6.1.3 Key Players – R&D Comparison
6.1.4 Key Players - Revenue Comparison
6.1.5 Key Players – Market Cap Comparison

7. Company Profiles
7.1 Bristol Myers Squibb
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Gilead Sciences, Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Allergan Plc (Tobira)
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Intercept Pharmaceuticals, Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Galmed Pharmaceuticals
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Genfit SA
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies

List of Tables

NASH Off-Label Therapies
Selected NASH Diagnosis Methods and Biomarkers under Development (2018)
Drugs under Development for NASH (2018)
Key Players – Product Portfolio Comparison (2018)
Key Players – Phase II clinical trials in NASH with histological endpoints Comparison
Key Players - Revenue Comparison (2018)
Key Players - Market Cap Comparison (2019)
Intercept Pharmaceuticals Product Pipeline (2018)
Genfit SA Product Pipeline (2018)

List of Figures

NAFLD Spectrum and Estimated Advancement Risk
Treatment of NASH
Potential Phase III NASH Drugs
Global NASH Drugs Market Forecast by Value (2018-2028)
Global NASH Drugs Market Value Forecast by Drug Class (2018/2023/2028)
Global NASH Off-Label Drugs Market Forecast by Value (2018-2028)
Global NASH Therapeutics Market Forecast by Value (2020-2028)
Global NASH Therapeutics Market Value Forecast by Drug Type (2023)
Global NASH Therapeutics Market Value Forecast by Drug Type (2028)
Global Obeticholic Acid (OCA) Drug Market Forecast by Value (2020-2028)
Global Obeticholic Acid (OCA) Drug Market Value Forecast by Region (2028)
Global Cenicriviroc (CVC) Drug Market Forecast by Value (2020-2028)
Global Cenicriviroc (CVC) Drug Market Value Forecast by Region (2028)
Global Elafibranor Drug Market Forecast by Value (2020-2028)
Global Aramchol Drug Market Forecast by Value (2022-2028)
Global MGL-3196 Drug Market Forecast by Value (2023-2028)
Global INN-217 Drug Market Forecast by Value (2023-2028)
Global VK2809 Drug Market Forecast by Value (2023-2028)
Global NASH Therapeutics Market Value Forecast by Region (2023)
Global NASH Therapeutics Market Value Forecast by Region (2028)
The U.S. NASH Therapeutics Market Forecast by Value (2022-2028)
Europe NASH Therapeutics Market Forecast by Value (2022-2028)
ROW NASH Therapeutics Market Forecast by Value (2022-2028)
The U.S. NASH Patient Population (2018-2028)
Global HealthCare Expenditure Per Capita (2014-2018)
Global Diabetic Population (2014-2018)
Global Obese Patient Population (2014-2018)
Number of NASH Patients treated with Ocaliva and Selonsertib Forecast (2020-2025)
Global Pharmaceutical R&D Expenditures (2014-2018)
Global E-Commerce Pharmaceutical Products Sales (2018-2023)
Drugs Approval Process
Key Players - R&D Comparison (2017-2018)
Bristol Myers Squibb Total Revenue and Net Earnings (2014-2018)
Bristol Myers Squibb Total Revenue by Segments (2018)
Bristol Myers Squibb Total Revenue by Regions (2018)
Gilead Sciences Total Revenues and Net Income (2014-2018)
Gilead Sciences Total Revenues by Business Segments (2018)
Gilead Sciences Total Revenues by Regions (2018)
Allergan Plc. (Tobira) Net Revenues and Net Loss (2014-2018)
Allergan Plc. (Tobira) Net Revenues by Segments (2018)
Allergan Plc. (Tobira) Net Revenues by Regions (2018)
Intercept Pharmaceuticals Revenue and Net Loss (2014-2018)
Intercept Pharmaceuticals Revenue by Segments (2018)
Galmed Pharmaceuticals Revenue and Net Loss (2014-2018)
Genfit SA Revenue and Net Loss (2014-2018)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs